SL Science Holding Ltd
SLBT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002070534
No open-market purchases or sales by SL Science Holding Ltd insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +9 vs. previous quarter
- 9
- 13F valueReported value at the end of Q2 2026
- $2.78M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SLBT, Q2 2026
No superinvestor reported holding SLBT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by SL Science Holding Ltd insiders from Form 4, newest first.
No open-market purchases or sales by SL Science Holding Ltd insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in SL Science Holding Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 193,404 | $926.4K | 0.00% | +193,404 | New |
| L1 Global Manager Pty Ltd | 150,000 | $718.5K | 0.58% | +150,000 | New |
| Rivernorth Capital Management, LLC | 130,000 | $622.7K | 0.03% | +130,000 | New |
| SkyView Investment Advisors, LLC | 42,042 | $201.0K | 0.16% | +42,042 | New |
| Heights Capital Management, Inc | 20,000 | $95.8K | 0.02% | +20,000 | New |
| Lynx Capital Group Ltd | 17,096 | $81.9K | 0.03% | +17,096 | New |
| Jane Street Group, LLC | 14,540 | $69.6K | 0.00% | +14,540 | New |
| UBS Group AG | 12,515 | $59.9K | 0.00% | +12,515 | New |
| Advisor Group Holdings, Inc. | 286 | $1.37K | 0.00% | +286 | New |